HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in World
World: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) was 87.0% in 2014. ▬ Flat
Latest (2014)
87.0%
Change on year
up 1.2%
Rank
3rd
of 11 groups
All-time high
96.0%
in 2004
All-time low
67.0%
in 2007
Years of data
12
2003–2014
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in World, 2003–2014
Source: World Health Organization, Global Health Observatory.
Analysis
In 2014, hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in World stood at 87.0%.
The figure is up 1.2% on the previous year and down 9.4% over ten years.
Over the whole period, hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in World peaked at 96.0% in 2004 and was at its lowest, 67.0%, in 2007.
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in World, year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 83.0% | — |
| 2004 | 96.0% | +15.7% |
| 2005 | 77.0% | -19.8% |
| 2006 | 84.0% | +9.1% |
| 2007 | 67.0% | -20.2% |
| 2008 | 72.0% | +7.5% |
| 2009 | 77.0% | +6.9% |
| 2010 | 81.0% | +5.2% |
| 2011 | 82.0% | +1.2% |
| 2012 | 84.0% | +2.4% |
| 2013 | 86.0% | +2.4% |
| 2014 | 87.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 79.4% | 67.0% | 96.0% | 7 |
| 2010s | 84.0% | 81.0% | 87.0% | 5 |
Countries ranked near World
- 1 Kuwait 100.0% compare
- 1 Pakistan 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Lebanon 100.0% compare
- 1 Fiji 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 Belize 100.0% compare
- 1 Egypt 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Brunei Darussalam 100.0% compare
- 1 Oman 100.0% compare
- 1 Comoros 100.0% compare
- 1 Angola 100.0% compare
- 1 Saint Lucia 100.0% compare
- 1 Bangladesh 100.0% compare
- 1 Lesotho 100.0% compare
- 1 Timor-Leste 100.0% compare
- 1 Albania 100.0% compare
- 1 Morocco 100.0% compare
More health data for World
- Population ages 15-19, male, annual growth rate 1.29 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0413 units per person (2025)
- Population ages 20-24, female, annual growth rate 0.7679 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0368 units per person (2025)
- Population ages 20-24, male, annual growth rate 0.8236 % change on previous year (2025)
- Population ages 20-24, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, male, per capita 0.0391 units per person (2025)
- Population ages 25-29, female, annual growth rate 0.3683 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in World?
- Hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in World was 87.0% in 2014, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in World?
- The highest recorded value was 96.0% in 2004.
- What is the lowest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in World?
- The lowest recorded value was 67.0% in 2007.
- How does World rank for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- World ranks 3rd out of 11 groups with data for 2014.
- Is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) rising or falling in World?
- Over the last ten years it is down 9.4%. The long-run trend across the full record is flat.
- Where does this World data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).